Skip to main content
. 2024 Jan 10;12(2):e02980-23. doi: 10.1128/spectrum.02980-23

Fig 2.

Fig 2

Change from baseline in SARS-CoV-2 viral load over time for patients with virologic rebound in the pomotrelvir (A) and placebo (B) groups. Individual graphs representing a change from baseline in SARS-CoV-2 RNA by treatment group for patients with virologic reboundt.